Development and differentiation in monobodies based on the fibronectin type 3 domain PG Chandler, AM Buckle Cells 9 (3), 610, 2020 | 45 | 2020 |
Adjuvant therapies in venous leg ulcer management: a scoping review V Team, PG Chandler, CD Weller Wound Repair and Regeneration 27 (5), 562-590, 2019 | 43 | 2019 |
Strategies for increasing protein stability PG Chandler, SS Broendum, BT Riley, MA Spence, CJ Jackson, ... Protein Nanotechnology: Protocols, Instrumentation, and Applications, 163-181, 2020 | 25 | 2020 |
Structural studies of thyroid peroxidase show the monomer interacting with autoantibodies in thyroid autoimmune disease DE Williams, SN Le, DE Hoke, PG Chandler, M Gora, M Godlewska, ... Endocrinology 161 (2), bqaa016, 2020 | 12 | 2020 |
Mutational and biophysical robustness in a prestabilized monobody PG Chandler, LL Tan, BT Porebski, JS Green, BT Riley, SS Broendum, ... Journal of Biological Chemistry 296, 2021 | 6 | 2021 |
Polymer End Group Control through a Decarboxylative Cobalt-Mediated Radical Polymerization: New Avenues for Synthesizing Peptide, Protein, and Nanomaterial Conjugates M Ayurini, PG Chandler, PD O’Leary, R Wang, D Rudd, KD Milewska, ... JACS Au 2 (1), 169-177, 2021 | 3 | 2021 |
Structure and dynamics of the autoantigen GAD65 in complex with the human autoimmune polyendocrine syndrome type 2-associated autoantibody b96. 11 S Stander, CF Reboul, SN Lee, D Williams, PG Chandler, MGS Costa, ... bioRxiv, 2024.03. 18.585568, 2024 | | 2024 |
Preclinical evaluation of targeted radionuclide therapy combined with immune checkpoint inhibition E Oosterwijk, S Kleidendorst, M Konijnenberg, R Merkx, ... European Urology 83, S1489, 2023 | | 2023 |
Preclinical evaluation of targeted radionuclide therapy combined with immune checkpoint inhibition S Kleinendorst, M Konijnenberg, R Merkx, K Twumasi-Boateng, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1), S58-S59, 2022 | | 2022 |
Potentiation of Immune Checkpoint Inhibition with Molecular-Targeted Radiation S Kleinendorst, P Chandler, E Oosterwijk, M Konijnenberg, ... Journal of Nuclear Medicine 63 (supplement 2), 4039-4039, 2022 | | 2022 |
Development and differentiation of hyperstable consensus monobodies based on the type 3 fibronectin domain PG CHANDLER Monash University, 0 | | |